APA

Lowin T., Pongratz G. & Straub R. H. (20160509). The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets. : Journal of inflammation (London, England).

Chicago

Lowin Torsten, Pongratz Georg and Straub Rainer H. 20160509. The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets. : Journal of inflammation (London, England).

Harvard

Lowin T., Pongratz G. and Straub R. H. (20160509). The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets. : Journal of inflammation (London, England).

MLA

Lowin Torsten, Pongratz Georg and Straub Rainer H. The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets. : Journal of inflammation (London, England). 20160509.